Raptor Pharmaceuticals

2 Orphan Drugmakers With Upcoming Catalysts
Seeking Alpha
Wed, 04/24/13 - 04:46 pm
orphan drugs
Raptor Pharmaceuticals
Aegerion
Juxtapid
procysbi
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Procysbi (Raptor Pharmaceuticals): A Long Acting Cysteine For The Treatment Of Cystinosis
Seeking Alpha
Wed, 03/27/13 - 09:56 am
Raptor Pharmaceuticals
procysbi
cystinosis
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Arena Pharmaceuticals
Sarepta
Ziopharm
Delcath
Aveo Pharmaceutical
United Therapeutics
AP Pharma
Titan Pharmaceuticals
Navidea Biopharmaceuticals
Biogen Idec
Raptor Pharmaceuticals
Why Raptor Could Run Up To Its PDUFA
Seeking Alpha
Tue, 02/12/13 - 10:59 am
Raptor Pharmaceuticals
Mylan
nephropathic cystinosis
RP103
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
JNJ
Invokana
SLGT-2 inhibitors
diabetes
Forxiga
Bristol-Myers Squibb
Pfizer
Raptor Pharmaceuticals
Raptor Drug FDA Action Date Delayed
Yahoo/Zacks
Fri, 12/28/12 - 11:26 am
FDA
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Several Reasons Why I'm Considering These 2 Biotech Firms Before Year's End
Seeking Alpha
Wed, 12/26/12 - 09:21 pm
Raptor Pharmaceuticals
Aegerion
Raptor Pharma Says FDA Extends PROCYSBI NDA Review By 3 Months
NASDAQ
Sat, 12/22/12 - 01:00 pm
procysbi
Raptor Pharmaceuticals
nephropathic cystinosis
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
Raptor cites R&D costs in fiscal 2012 loss
bizjournals
Sat, 11/17/12 - 02:43 pm
Raptor Pharmaceuticals
earnings
Raptor Pharmaceuticals announces positive data on RP103 extension study
The Fly on the Wall
Mon, 11/5/12 - 11:02 am
RP103
Raptor Pharmaceuticals
nephropathic cystinosis
Raptor Pharma Rises as FDA Starts Drug Review
PharmPro
Sat, 06/16/12 - 01:52 pm
RP103
Raptor Pharmaceuticals
nephropathic cystinosis
26 Drugs Facing FDA Approval in 2012
TheStreet.com
Wed, 05/2/12 - 11:12 am
drug approvals
FDA
Regeneron
ONYX Pharmaceuticals
Pfizer
Celgene
Arena Pharmaceuticals
Alexa
Gilead
Merck
Ironwood
Vivus
Navidea Biopharmaceuticals
NPS Pharmaceuticals
Raptor Pharmaceuticals
Santarus
Biogen Idec
Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis
Pipeline Review
Sat, 03/31/12 - 01:11 pm
Raptor Pharmaceuticals
RP103
nephropathic cystinosis
Biotech Focused Hedge Fund RA Capital's Top Q3 Picks
Seeking Alpha
Sun, 11/20/11 - 12:21 pm
Columbia Laboratories
Sequenom
Raptor Pharmaceuticals
Raptor Pharma rises as analyst gives top rating
BusinessWeek
Sat, 09/17/11 - 05:22 pm
DR Cystamine
Raptor Pharmaceuticals
cystinosis
Raptor Pharmaceuticals Announces Positive Phase 3 Trial Results: Shares Tumble
Seeking Alpha
Sat, 07/30/11 - 10:21 am
Raptor Pharmaceuticals
RP103
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tue, 07/12/11 - 10:27 am
Targacept
Aveo Pharmaceutical
Threshold Pharmaceuticals
Raptor Pharmaceuticals
Vertex Pharmaceuticals
Soligenix
Spectrum Pharmaceuticals
NuPathe
Pharmasset
Incyte
Adventrx
Celsion
Alimera
GTx
Ariad Pharmaceuticals
Biotech Catalysts for Q2 2011
Seeking Alpha
Thu, 04/7/11 - 10:09 am
biotech
XenoPort
Titan
Raptor Pharmaceuticals
Adeona
Delcath

Pages